首頁/CI

公开研究页

行情来自市场数据接口;下方公司研究基于已核验公开来源,但不等同于实时、个性化的 AI 投资结论。

去工作台分析 CI
CINYSE/health care

The Cigna Group

$304.50上涨+11.04 (+3.76%)
研究复核截至: 2026年7月12日 上午12:00 [UTC]
研究概览近 3 个月价格投资论点关键催化剂最新财报研究近期新闻数据与研究来源

研究概览

The Cigna Group operates in Managed Health Care within the health care sector. This profile tracks its company-specific earnings drivers, valuation conditions, and primary-source risks.

開盤
295.75
最高
305.25
最低
294.88
市值
805.5億
本益比
12.91
52 週高點
--
股息
2.130%
季度股利金額
--

近 3 个月价格

這裡展示近 3 個月價格走勢,幫助使用者先理解短期結構,再決定是否進入完整研究工作台。

投资论点

基础情景
Specialty pharmacy, care services and benefit-management scale can deepen relationships with health-plan clients. The base case remains conditional on pbm policy change staying manageable.
多头情景
Specialty pharmacy, care services and benefit-management scale can deepen relationships with health-plan clients. Growth in complex therapies can increase demand for specialty distribution, pharmacy and adherence services. Strong cash generation can support repurchases and debt reduction when operating targets are met.
空头情景
New rules on rebates, spread pricing or transparency could reduce benefit-management profitability. Loss or repricing of large health-plan and employer contracts can create meaningful revenue volatility. Unexpected utilization can pressure the healthcare segment despite underwriting discipline.
论点失效条件
Reassess the thesis if new rules on rebates, spread pricing or transparency could reduce benefit-management profitability.

关键催化剂

  • Evernorth growth

    Specialty pharmacy, care services and benefit-management scale can deepen relationships with health-plan clients.

  • Specialty medicines

    Growth in complex therapies can increase demand for specialty distribution, pharmacy and adherence services.

  • Capital returns

    Strong cash generation can support repurchases and debt reduction when operating targets are met.

主要风险

  • PBM policy change

    New rules on rebates, spread pricing or transparency could reduce benefit-management profitability.

  • Client concentration and retention

    Loss or repricing of large health-plan and employer contracts can create meaningful revenue volatility.

  • Medical-cost execution

    Unexpected utilization can pressure the healthcare segment despite underwriting discipline.

最新财报研究

Q1 2026

The Cigna Group's first-quarter 2026 results reflected continued Evernorth pharmacy and health-services growth alongside disciplined execution in Cigna Healthcare and active capital returns.

估值解读

  • Evernorth's recurring service model supports cash generation, but policy durability is central to the multiple.
  • Capital returns should be judged after allowing for client retention, medical-cost volatility and regulatory investment.

同行比较入口

UNHELVABBV

近期新闻

StockStory · 2 小時前

Why Cigna (CI) Stock Is Up Today

Trefis · 8 小時前

The Premium On CVS Stock Vs What Its Peers Deliver

Trefis · 4 天前

UNH Showered Owners With Cash. The Stock Did Not Cooperate

Barchart · 4 天前

What to Expect From Cigna's Next Quarterly Earnings Report

Trefis · 5 天前

The Real Price Of UnitedHealth Stock Isn't On Today's Label

Zacks · 7 天前

UnitedHealth Bets on Profitability Over Growth: Will It Pay Off?

在工作台中继续研究

保留 CI,运行多智能体分析并持续跟踪论点变化。

免费分析 CI

探索完整研究體系

每個階段職責明確,並為下一階段留下可追溯的輸出。

研究方法論閱讀市場報告

数据与研究来源

研究更新: 2026年7月12日 上午12:00 [UTC]
3 个已核验来源
The Cigna Group Reports First Quarter 2026 ResultsThe Cigna Group · earnings已核验

抓取时间: 2026/7/12 上午12:00:00 [UTC]

发布时间: 2026/5/1 上午12:00:00

查看原始来源
The Cigna Group Investor RelationsThe Cigna Group · company已核验

抓取时间: 2026/7/12 上午12:00:00 [UTC]

查看原始来源
The Cigna Group SEC filings and company factsU.S. Securities and Exchange Commission · filing已核验

抓取时间: 2026/7/12 上午12:00:00 [UTC]

发布时间: 2026/5/1 上午12:00:00

查看原始来源
瀏覽股票

继续深挖这只股票

市場分析 Agent

負責先判断价格結構、趋势强弱與交易節奏有没有支持 thesis。

基本面分析 Agent

負責判断公司的业务质量、盈利結構與财务健康度。

新闻分析 Agent

追踪最近发生了什么,以及這些事件是否真的改变 thesis。

風險经理 Agent

負責在風險辩論后给出最终風險等級和执行邊界。